INS and type 1 diabetes mellitus: Insulin, whether administered systemically or locally, consistently showed benefits in enhancing BIC%, peri-implant bone density, and mechanical retention in both T1DM and T2DM animal models, underscoring its important role, not only in glycemic control, but also in bone metabolism and remodeling.